... Molecular pathology Gastric cancer (GC) was the third leading cause of cancer-related deaths worldwide in 2020 [ 1, 2 ] and is characterized by a heterogeneous disease with different phenotypes [ 3 ]. Despite extensive efforts to improve treatment methods, GC continues to cause over 700,000 deaths...

... carcinoma Protocadherin B9 Molecular pathology Esophageal cancer is the sixth leading cause of cancer-related death and the ninth most common cancer worldwide [ 1 ]. Esophageal squamous cell cancer (ESCC) accounts for more than 90% of esophageal cancer cases [ 2 ]. ESCC can be classified...

... treatment approaches in MDS. [email protected] 20 02 2018 22 03 2018 23 5 2018 By the use of newer sequencing techniques such as next-generation sequencing (NGS), the landscape of molecular pathology in MDS is on the way to being deciphered. Large studies of whole...

..., instructions or products referred to in the content or advertisements. Lung cancer Heterogeneity Molecular pathology Genetics Lung cancer is one of the most frequently diagnosed cancers, especially in developed countries. Despite recent developments in the diagnosis, classification...

...-François Fléjou Service d Anatomie et Cytologie Pathologiques, Hôpital Saint-Antoine, AP-HP, Faculté de Médecine Pierre-et-Marie-Curie, et INSERM UMRS 938, Paris, France Key Words Gastrointestinal cancer Colon cancer Molecular pathology Targeted therapy Abstract Gastrointestinal cancer treatment...

... differential diagnoses, and the proper use of ancillary techniques. Bone marrow Immunohistochemistry Molecular pathology 24 11 2006 26 01 2007 25 6 2007 © 2007 S. Karger AG, Basel 2007 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

... genes that correlate with a particular stage of carcinogenesis can ultimately be compared within or between individual patients. Thus, these new technologies will have an enormous impact on molecular pathology with several diagnostic, prognostic and therapeutic implications. 16 6 2000 © 2000...